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Physical and functional interconnectivity  
of the ER
The ER is a central coordinator of diverse cellular processes. 
Most notably, the ER acts as gatekeeper to the secretory pathway 
by  folding,  modifying,  and  exporting  nascent  secretory  and 
transmembrane proteins, together encompassing 30% of the 
cellular proteome, en route to their final destinations within the 
endomembrane system. The ER also stores calcium for localized 
release by second messenger cascades. Lipogenic reactions (in-
cluding those involved with synthesis of triacylglycerols, sterols, 
ceramides, and most cellular phospholipids) occur on the cyto-
solic face of the ER membrane, as does fatty acid desaturation. 
Enzymes involved in gluconeogenesis and specialized pathways 
of fatty acid oxidation are also housed at the ER. The ER forms 
the nuclear envelope and can contribute to biogenesis of peroxi-
somes, lipid droplets, and autophagic membranes. The ER makes 
close contacts with every other membranous structure in the cell, 
and these contacts likely facilitate the bidirectional transfer of 
lipids, calcium, and other molecules. This physical and func-
tional interconnectivity imparts upon the ER a central role in the 
maintenance of numerous aspects of cellular and organismal   
homeostasis. Thus, disruption of ER function broadly impacts 
cellular function, and disruptions in other cellular processes 
typically redound to the ER.
Because the ER has to effectively carry out its many func-
tions even as external conditions act upon it, it must communicate 
bidirectionally with other cellular signaling cascades. The organ-
elle must be able to sense and integrate information about the   
nature, intensity, and duration of perturbations to it and to adjust 
cellular pathways accordingly to maintain homeostasis. The ER 
response to nutrient flux necessarily differs from its response to 
infection by a pathogen that usurps the secretory pathway or from 
its response to a differentiation stimulus that necessitates ER   
expansion. It is now becoming clear that the unfolded protein   
response (UPR), a signaling pathway from the ER to the nucleus 
which is best characterized as a stress response, has been drafted 
into the role of regulator of basal homeostasis and that the UPR 
provides a signaling framework into which other cellular path-
ways are intimately integrated. In this review, we discuss recent 
findings that shed light on how different physiological stimuli can 
activate the UPR, how intersection between the UPR and other 
signaling cascades allows its output to be modulated, and how the 
UPR might contribute to diseases beyond those that can be read-
ily rationalized as protein folding disorders. Thus, we strive to 
highlight the underappreciated but emerging role of the UPR in 
buffering normal fluctuations in cellular state to facilitate mainte-
nance of cellular homeostasis.
Evolutionary expansion of ER  
signal transduction
The observation that toxin-mediated impairment of ER protein 
folding  leads  to  transcriptional  induction  of  ER  chaperones 
spurred the search for signaling mechanisms from the ER to the 
nucleus (Kozutsumi et al., 1988; Dorner et al., 1990). This stress 
paradigm proved to be a powerful guide in uncovering the ER 
The extensive membrane network of the endoplasmic retic-
ulum (ER) is physically juxtaposed to and functionally en-
twined with essentially all other cellular compartments. 
Therefore, the ER must sense diverse and constantly chang-
ing physiological inputs so it can adjust its numerous func-
tions to maintain cellular homeostasis. A growing body of 
new work suggests that the unfolded protein response 
(UPR), traditionally charged with signaling protein misfold-
ing stress from the ER, has been co-opted for the mainte-
nance of basal cellular homeostasis. Thus, the UPR can be 
activated, and its output modulated, by signals far outside 
the realm of protein misfolding. These findings are reveal-
ing that the UPR causally contributes to disease not just by 
its role in protein folding but also through its broad influ-
ence on cellular physiology.
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of UPR regulation, we begin with an overview of the basic ver-
tebrate UPR signaling pathways.
The vertebrate UPR
The vertebrate UPR uses three ubiquitous branches defined by 
the  ER-resident  transmembrane  proteins  IRE1-,  PERK,  and 
ATF6-. Although the PERK and ATF6- pathways also exist in 
simpler metazoans such as flies and worms, they appear to carry 
out more specialized functions than their vertebrate counterparts. 
During acute ER perturbation, these pathways rapidly reduce 
protein import into the ER by several distinct mechanisms. The 
best described of these is a robust and nonspecific inhibition of 
most mRNA translation as a consequence of eIF2- phosphory-
lation by PERK (Harding et al., 2000). ER load is also attenuated 
by  IRE1-–mediated  degradation  of  select  ER-associated 
mRNAs, a process named regulated IRE1-dependent decay 
(RIDD; Hollien and Weissman, 2006). Finally, preemptive qual-
ity control selectively inhibits the translocation of certain proteins 
into the ER depending on properties of their ER targeting signal 
peptides (Kang et al., 2006). The possibility that these mecha-
nisms might act in a more substrate-specific way during physio-
logical UPR activation is conceptually appealing but has not been 
explored in depth.
Each UPR pathway also culminates in transcriptional regu-
lation via unique mechanisms (for review see Ron and Walter, 
2007): activated IRE1- facilitates removal of a short intron from 
Xbp1 mRNA, allowing translation of full-length XBP1; activated 
ATF6-  is  processed  by  regulated  intramembrane  proteolysis 
to liberate its N-terminal transcriptional activator domain; and 
activated PERK phosphorylates the translation initiation factor 
eIF2-, which stimulates translation of ATF4. Together (and with 
considerable overlap among them), XBP1, ATF6-, and ATF4   
regulate genes encoding ER chaperones, ER-associated degra-
dation factors, amino acid transport and metabolism proteins, 
phospholipid biosynthesis enzymes, and numerous others, includ-
ing many that have no obvious direct relationship to secretory 
signal transduction pathways that collectively became known as 
the UPR (for review see Ron and Walter, 2007). In yeast, the 
UPR is defined by a single linear pathway initiated by the ER-
resident transmembrane kinase Ire1p and the downstream tran-
scription factor Hac1p (Sidrauski et al., 1998). Transcriptional 
profiling has delineated the hundreds of Hac1p targets (i.e., the 
output of the yeast UPR; Travers et al., 2000), whereas compre-
hensive whole-genome analysis has identified genes that, when 
disrupted, activate the UPR (i.e., pathways that generate inputs 
for the UPR; Jonikas et al., 2009). Not unexpectedly, the inputs 
and outputs partially overlap and, to a first approximation, can 
be largely explained by a simple model in which the inputs im-
pinge upon ER protein folding, whereas the output represents a 
transcriptional program designed to augment ER functionality 
and restore the organelle to its prestress state. In this context, 
the UPR acts as a closed signaling loop, with discrete and self-
limited start and endpoints.
This core UPR has been markedly expanded during ver-
tebrate evolution in three qualitatively different ways (Fig. 1). 
First, multiple ER-resident stress sensors in addition to IRE1 
initiate complementary signaling pathways, all of which can 
regulate transcription. Second, UPR output is regulated by 
multiple  means,  both  transcriptional  and  nontranscriptional. 
Third, many components of these UPR signaling cascades are 
themselves subject to regulation in trans by other cellular path-
ways. These evolutionary increases in complexity have greatly 
widened the scope of UPR signal transduction in terms of both 
the broader range of physiological inputs that influence UPR 
activity and the more nuanced outputs that are customized to 
cellular need. The major consequence of vastly expanded UPR 
signaling is the regulatory influence of cellular pathways that 
function well outside the realm of ER protein processing. Thus, 
it is increasingly clear that what began as an organelle-specific 
stress response has expanded into a complex signaling network 
that plays a central homeostatic role in normal vertebrate physiology.   
To provide an understanding of these newly emerging complexities   
Figure 1.  Evolutionary expansion of the UPR 
allows for regulatory modulation and variable 
inputs  and  outputs.  The  evolutionarily  con-
served IRE1 arm of the UPR (green) has been 
expanded in metazoans by the parallel PERK 
and ATF6 pathways (blue). Each of these stress 
transducers  is  sensitive  to  protein  misfolding 
stress in the ER, and they collectively contribute 
to gene regulation and UPR output. Each trans-
ducer can also interact with additional factors 
(orange) shared with signaling pathways re-
sponsive to other stimuli. These accessory in-
teractions can thereby modulate the canonical 
stress  response  output  contingent  on  cellular 
conditions.  Physiological  stimuli  can  further 
shape UPR outputs by differentially acting on 
the UPR at both proximal and distal steps. Two 
illustrative  examples  are  depicted  using  red 
and black dashed lines. In the first example, 
TLR engagement activates all three UPR trans-
ducers, while simultaneously suppressing ATF4 
production (Woo et al., 2009). TLR-stimulated UPR-independent pathways operate in parallel, such that TLR stimulation influences and is influenced by UPR 
activation to determine the final output. The second example illustrates plasma cell differentiation, where a differentiation stimulus initiates a differentiation 
program that includes selective activation of the ATF6- and IRE1- pathways of the UPR. The UPR pathways increase ER protein processing capacity, 
thereby facilitating the high level of antibody production and secretion that accompanies differentiation (Gass et al., 2008; Ma et al., 2010). The selectivity 
of UPR activation in this case precludes PERK-mediated responses, which might act at cross-purposes to differentiation.785 Physiologic regulation of the UPR • Rutkowski and Hegde
by that cell, probably does not accurately capture the major physio-
logical roles of the vertebrate UPR. Although the UPR is cer-
tainly a necessary element of the protective response against 
pathological conditions (for review see Otsu and Sitia, 2007), 
here we focus on how normal physiological signaling intersects 
with the UPR to regulate its activation and its output, toward the 
goal of maintaining normal cellular function. In this view, the   
input is defined by the physiological stimuli that activate part or all 
of the UPR, whereas the output constitutes the adjustments to 
cellular function, mediated by both transcriptional and nontran-
scriptional mechanisms.
Physiological engagement of UPR pathways
To be used for physiological regulation and to have sufficient 
flexibility given the multitude of ER functions, the UPR must 
be capable of discriminating among a broad variety of activation 
stimuli (inputs) and initiating appropriate responses. Although 
positive and negative feedback loops within the UPR can intrin-
sically produce distinct outputs in proportion to the strength of 
input (Rutkowski et al., 2006), the ways in which the stress sen-
sors are activated by physiological stimuli must necessarily be 
more nuanced than can be accounted for by postulating a single 
uniform mechanism of activation. Although client load in excess 
of the folding capacity of ER chaperones (in particular BiP) is 
generally thought of as the primary inducer of the UPR, this ex-
planation seems limited for at least two reasons. First, misfolded 
proteins as the sole input would make tuning the response in 
all but the most limited manner quite difficult, and it would not   
provide for discrimination among qualitatively distinct inputs. 
Consistent with this idea, pharmacological perturbants that broadly 
impair ER protein folding activate either all three UPR pathways 
together or none at all if the dose is insufficient (Rutkowski et al.,   
2006). Second, according to a simple misfolded protein accu-
mulation mechanism, the UPR would necessarily be reactive   
to altered conditions and could never be proactively induced.   
Although a strictly reactive system is appropriate when the need for   
a response is rare, unpredictable, and intermittent, it seems less 
desirable when requisite changes to ER functionality can be fully 
anticipated as part of normal physiology. Indeed, requiring ER 
impairment in order for the UPR to be activated in response to 
physiological stimuli such as differentiation cues or in prepara-
tion for cell division is an unsatisfying proposition. Therefore, 
it is reasonable to posit that there are many distinct physiologi-
cal UPR activation states and that these represent the first step in 
generating diverse outputs. The following observations support 
this view and provide a range of interesting examples of physio-
logical UPR activation.
Although yeast appear to use the UPR almost exclusively 
as a stress response, nascent physiological uses are apparent even 
in this context. Specifically, low-level cell cycle–dependent UPR 
activation under normal growth conditions suggests a stress- 
independent housekeeping role for the UPR, the absence of which 
leads to defective cytokinesis (Bicknell et al., 2007). Indeed, dou-
bling of the ER (and indeed, of all the membranous content of the 
cell) is necessary in all eukaryotes, and so it is logical that this 
functionality of the UPR would be found even in yeast. Of course, 
in vertebrates, there are far more circumstances in which it would 
pathway function. The vertebrate IRE1- and ATF6- para-
logues (IRE1- and ATF6-) add further complexity (Bertolotti 
et al., 2001; Thuerauf et al., 2007), as do several tissue-specific 
ATF6-like ER-resident transcription factors (such as CREB-H, 
OASIS, Luman, and others) that can be activated by regulated   
intramembrane proteolysis (Bailey and O’Hare, 2007). Although 
these paralogues and orthologues remain relatively poorly stud-
ied to date, it is clear that they can be responsive to changes in 
ER physiology and are increasingly considered under the gen-
eral UPR umbrella (e.g., Zhang et al., 2006). Thus, even the 
aforementioned oversimplified description of the vertebrate UPR 
highlights the considerable complexity of signal transduction 
emanating from the ER.
Vertebrate diversity necessitates an 
expanded UPR
One reason for contrasting the yeast and vertebrate UPR path-
ways, besides providing essential background, is to consider why 
the latter has evolved such elaborate complexity when a single 
pathway analogous to the yeast UPR should be sufficient to up-
regulate ER chaperones when protein folding is disrupted. The 
most plausible explanation is that an expanded UPR provides 
greater flexibility: a wider range of inputs can be accommodated 
by the multiple overlapping but distinct pathways, and the out-
puts of multiple, branched, and intersecting signaling pathways 
can be finely tuned to cellular need (Fig. 1).
This greater level of regulation in vertebrates is necessi-
tated by the diversity of differentiated cell types, the individual 
requirements of these cell types for proper function, the consid-
erably different environments in which these cells normally op-
erate, and the different ranges in environmental parameters that 
these cells can expect to encounter. For example, some cell 
types (e.g., differentiated neurons) enjoy remarkably constant 
nutrient supplies, steady demands on the secretory pathway, a 
lack of cell division, and a minimum of morphological changes 
that require modification of the membrane production program. 
In contrast, other cells experience widely ranging flux through 
the secretory pathway (e.g., endocrine cells), substantial varia-
tions in the types of nutrients that are metabolized (e.g.,   
hepatocytes), regular exposure to various toxic substances 
(e.g., macrophages), or widely varying oxygen tensions (e.g., 
alveolar cells). Thus, the normal range of physiological and en-
vironmental parameters faced by one cell type may be vastly 
different than that encountered by another cell type in the 
same organism.
This diversity among cell types means that some cells regu-
larly adjust the functionality and capacity of their ER, whereas 
others maintain a comparatively constant steady-state (not unlike 
a typical tissue-culture cell). Consequently, UPR signaling is al-
most certainly used even during the course of normal organismal 
physiology to tune ER functionality in response to changing de-
mands. Indeed, it is increasingly evident that in vertebrates, UPR 
signaling can be initiated without necessarily exceeding the   
protein-processing capacity of the ER, the traditional definition 
of ER stress. Thus, the stress paradigm, which we define for the 
purposes of this review as the experience of ER conditions that lie 
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suggest some possibilities (Fig. 2). One of these is that selective   
physiological activation of the UPR could be achieved by a more 
nuanced aspect of the chaperone/client protein balance. In this 
view, accumulation of specific ER client proteins might trigger 
UPR activation even as global folding remains unperturbed. For 
example, B lymphocytes up-regulate numerous cell surface re-
ceptors during differentiation (Hardy and Hayakawa, 2001), and 
it is conceivable that one or more of these might stimulate UPR 
signaling in a selective manner. Although all three stress sensors 
are activated by global ER dysfunction, differences in their ac-
tivation mechanisms could impart substrate specificity in some 
cases. In support of this idea, ATF6- activation is influenced   
by its oxidation state, glycosylation state, and proteasome- 
dependent turnover (Hong et al., 2004a,b; Nadanaka et al., 2006; 
Yoshida et al., 2009; Fonseca et al., 2010). Thus, stimuli that 
preferentially alter these aspects of ER protein processing (for 
example, up-regulation of protein that is particularly demand-
ing of the ER oxidation and isomerization activity) could favor 
ATF6- activation more than other pathways. Pathway-selective 
stimulation could be further facilitated if protein folding and 
UPR transduction are subcompartmentalized within the ER, as 
has been recently suggested (Kondratyev et al., 2007).
Another possible mechanism for proactive UPR induction, 
not mutually exclusive with the first, is that UPR activation can 
occur independently of protein folding. As proof of principle,   
artificial dimerization of PERK and IRE1- was shown to allow 
their stress-independent activation (Papa et al., 2003; Lu et al., 
2004). Thus, one might imagine physiological stimuli that achieve 
the same outcome, for instance, the existence of endogenous fac-
tors or even small molecule ligands that can scaffold sensor self-
association. This idea is supported by the observation that the 
flavonol quercetin can stimulate dimerization and activation of 
yeast Ire1p (Wiseman et al., 2010). It is important to emphasize 
that both of these possibilities are purely hypothetical at this 
point. The mechanisms of sensor activation, even during classical 
ER stress, remain unresolved, and mechanisms both dependent 
and independent of direct binding to misfolded proteins by the 
proximal stress sensors have been proposed (Credle et al., 2005; 
Zhou et al., 2006; Oikawa et al., 2009).
In addition to proactive UPR engagement preceding dra-
matic cell-shaping exogenous stimuli such as differentiation cues, 
the UPR is also likely to be activated to maintain cellular function 
in the face of normal fluctuations of a cell’s physiological state. 
Such a basal function is evident from the observation that UPR 
activation is apparent in some cells and tissues of normal mice 
under normal conditions. For example, a GFP reporter for Xbp1 
activation was observed in situ in both pancreas and muscle 
(Iwawaki et al., 2004). Similar reporters applied to several other 
cell types (mammalian B and T cells [Brunsing et al., 2008], den-
dritic cells [Hayashi et al., 2007], and placenta [Iwawaki et al., 
2009] among others) provide further support for Xbp1 splicing 
under various stress-free physiological settings. Although less ex-
tensively characterized, activated forms of other UPR pathways 
components, including ATF4, ATF6, and PERK, have been de-
tected in various tissues of unchallenged mice (Harding et al., 
2000; Yang et al., 2004; Lee et al., 2008; Wang et al., 2009), de-
spite the fact that these forms are not usually detected in cultured 
be advantageous for the UPR to anticipate impending demand   
on the ER and/or secretory pathway and to proactively adjust cel-
lular physiology.
The most dramatic example of a proactive UPR is during 
development,  when  many  cell  types  must  drastically  expand 
their ER upon differentiation. For example, the differentiation of 
B cells into antibody-producing plasma cells requires the UPR 
(Iwakoshi et al., 2003), presumably for expansion of the ER to 
handle the markedly increased secretory pathway load generated 
by up-regulated Ig synthesis. Although it seems logical that Ig 
induction would cause ER stress, activate the UPR, and initiate a 
responsive up-regulation of ER, this does not appear to be the 
case. Instead, differentiation-inducing stimuli lead to substantial 
ER expansion via activation of the IRE1- and ATF6- path-
ways before significant Ig synthesis occurs (van Anken et al., 
2003). More dramatically, B cells engineered to lack Ig produc-
tion nevertheless activate Xbp1 and differentiate normally (Hu   
et al., 2009). These findings call into question the causal role of ER 
stress in inducing the UPR in this context. It seems, rather, that 
Xbp1 (and perhaps other UPR pathways) are activated in prepa-
ration for rather than in response to secretory pathway load; in 
other words, a cell need not wait for dysfunction in the ER to   
alter its capacity. Although the mechanisms underlying UPR   
activation in plasma cell differentiation remain to be clarified, 
these observations emphasize that, depending on cellular context, 
UPR pathway components are capable of being activated in a se-
lective and stress-independent fashion to regulate ER structure 
and function.
Proactive UPR activation may be used in several other con-
texts besides development. For example, diurnal induction of the 
UPR (and changes in its responsiveness) has been observed and 
is dependent on the circadian clock (Cretenet et al., 2010).   
Because nutritional flux and metabolism, which involve numerous 
facets of ER biology (see UPR pathway interactions in disease), 
are both predictable and typically diurnal, a mechanism to pre-
pare the ER seems entirely appropriate. The UPR can also be 
triggered via signaling from the extracellular environment. For 
example, stimulation of thyrocytes with thyroid-stimulating hor-
mone leads to up-regulation of ER chaperones, apparently in 
preparation for the increased load demanded by the need to make 
thyroglobulin (a large, slowly maturing secretory protein; Christis 
et al., 2010). Similarly, Toll-like receptors (TLRs), which signal 
the existence of pathogens, can modulate UPR signaling (Woo   
et al., 2009). This too makes logical sense because of the foresee-
able increase in demands on the ER in the context of the stress of 
combating infection, presenting foreign antigens, and so forth. 
Thus, preparative UPR activation may well be protective in each 
of these circumstances by adjusting cellular physiology to a state 
more able to deal with impending environmental or physiological 
changes. Although this prepared state likely features a function-
ally and/or physically expanded ER, the ability of the UPR to 
regulate diverse cellular processes suggests that other functions 
of the UPR besides ER expansion might be as important or even 
more so during proactive UPR signaling.
Appealing as a proactive engagement process is, there is still 
no mechanistic understanding of how it might work, although re-
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under normal conditions. Thus, the UPR, in addition to being cru-
cial to sensing and responding to presumably rare and sporadic 
protein misfolding stress, is physiologically engaged by many 
other cellular pathways (developmental, cell surface signaling, 
circadian, and others). These results suggest that the UPR, or at 
least elements of it, are frequently or perhaps even continually 
activated in some cell types as a means of fine-tuning cellular 
conditions in real time.
UPR functionality is context dependent
Because physiological uses of the UPR occur in rather diverse 
cellular contexts, its output is likely to be tailored to the stimulus. 
This raises several key questions. How broad is the range of UPR 
outputs that can be achieved by the cell? Is this range simply 
quantitative (i.e., a strong vs. weak response), or is UPR output 
substantively and qualitatively diverse? And how would context-
dependent diversity in outputs be generated?
The fact that signal transduction pathways can generate dif-
ferent outputs depending on cellular context is well established in 
many systems. An obvious example would be MAPK signaling, 
whose effects on downstream gene expression depend greatly on 
the stimulus that induces it, the complement of modifier proteins 
expressed in a given cell type, and the activity of parallel signal-
ing pathways (Shaul and Seger, 2007). An important requirement 
in such systems is that key components of a signaling cascade are 
sensitive to trans-acting modifiers that can influence their abun-
dance or activity. Because such modifiers may vary depending on 
conditions or cell type, responsiveness of the signaling pathway 
would be variable. Thus, the physiological, environmental, ge-
netic, developmental, and historical state of the cell would deter-
mine the context within which a signaling pathway acts, which 
cells that have not been subjected to acute stress. Thus, it is likely 
that these transcription factors are contributing to the basal regu-
lation of gene expression in vivo, although their precise roles are 
currently poorly defined.
Physiological roles for the UPR have been challenging to 
study because of early lethality in animals with constitutive dele-
tions in UPR components (IRE1-, XBP1, and PERK). However, 
conditional gene deletion studies are overcoming this problem 
and providing insights into the situations in which UPR signaling 
is important during normal physiology. Mice in which Xbp1 was 
ablated in the adult liver show no evidence for ER stress or a gen-
eral impairment of the secretory pathway but show a marked   
reduction in serum cholesterol, triglyceride, and free fatty acid 
(Lee et al., 2008). The expression of a subset of lipogenic genes 
was reduced in these animals, suggesting that XBP1 contributes 
to lipid homeostasis in the liver through the regulation of these 
genes. The gut-specific IRE1- paralogue IRE1- also regulates 
lipid  metabolism,  as  the  RIDD  activity  of  IRE1-  regulates   
chylomicron  production  in  the  intestine  (Iqbal  et  al.,  2008). 
Similarly, eIF2- maintains homeostasis in pancreatic  cells; 
inducible ablation of eIF2- phosphorylation in the adult pan-
creas leads to rapid and severe -cell dysfunction and diabetes, 
accompanied by unregulated protein translation in these cells 
(Back et al., 2009). Finally, acutely knocking down hepatic   
ATF6- expression using an adenoviral vector results in elevated 
expression of gluconeogenic genes and hyperglycemia, effects 
which have been attributed to competition between ATF6- and 
the metabolic transcriptional regulator CREB for interaction with 
the coregulator CRTC2 (Wang et al., 2009). Collectively, these 
examples provide prima facie evidence that all three pathways of 
the UPR are active to one extent or another in at least certain tissues 
Figure  2.  Potential  activation  mechanisms 
for the UPR during physiological stimulation. 
(A) Global protein misfolding stress in the ER 
results in activation of all three UPR sensors. 
ER chaperones (blue) can maintain UPR signal 
transducers in an inactive state during quies-
cent conditions. Unfolded proteins can activate 
the  stress  transducers  by  indirect  chaperone   
titration  or  direct  transducer  binding.  The 
global  balance  between  chaperone  reserve 
and ER folding clients might represent the stim-
ulus  for  physiological  activation  of  the  UPR, 
with parallel signaling pathways modifying the 
activity and/or abundance of phosphatases, 
proteases, nucleases, etc. that determine net 
UPR output. However, it is likely that at least 
some physiological stimuli are capable of ac-
tivating UPR pathways selectively by several   
hypothetical mechanisms. (B) First, a UPR sensor 
could be preferentially sensitive to the folding 
status of certain types of substrates or specific 
environmental  conditions  (e.g.,  redox  status; 
left). Second, spatial restriction of UPR trans-
ducers and/or individual substrates might lead 
to  localized  preferential  activation  (middle). 
And  third,  stimulated  dimerization  of  IRE1- 
or PERK in trans (or enforced ectopic transit 
of ATF6- to the Golgi, where it is activated) 
could activate limbs of the UPR independently 
of the ER folding status. These or other hypo-
thetical mechanisms might be used during dif-
ferent physiological stimuli, and they need not 
be mutually exclusive.JCB • VOLUME 189 • NUMBER 5 • 2010   788
can take place without the apoptotic consequences. Thus, the 
aforementioned examples make it clear that a benefit of the ver-
tebrate UPR, with its multiple pathways and multiple steps in 
each pathway, is that the response’s output can be finely modu-
lated based on the points at which it is regulated by intrinsic and 
extrinsic factors.
In addition to the dichotomy between adaptation and apop-
tosis, other more nuanced outputs of the UPR can also be regu-
lated. The basic principle of this regulation typically is based on 
the sharing of components between the UPR and other signaling 
pathways. This kind of cross talk can bidirectionally impact the 
output of both signaling pathways, allowing each to be modified 
by the other. Different mechanisms of pathway intersection have 
been described for each of the three primary limbs of the UPR. 
For example, the activity of ATF6- is influenced by its interac-
tion with the transcriptional coregulator CRTC2 (Wang et al., 
2009). This interaction links UPR activity to the status of cellular 
metabolic pathways because CRTC2 also serves as a coactivator 
for CREB, a transcription factor which (among many things) is 
responsive to glucagon signaling. Therefore, UPR activation   
influences the metabolic state by sequestering CRTC2 through 
ATF6-, thereby altering CREB activity. Conversely, concurrent 
glucagon stimulation would tend to titrate CRTC2 away from 
ATF6-, potentially regulating UPR output. As another example 
of regulation of ATF6- transcriptional output in trans, the ATF6- 
influence on BiP expression is counteracted by HDAC1 (histone 
deacetylase 1)-mediated repression (Baumeister et al., 2009). 
Thus, the balance between UPR activation and external regula-
tion of the histone machinery in a physiologically activated UPR 
is expected to control the ultimate output.
The PERK and IRE1 pathways also intersect with non-
UPR signaling cascades. For PERK, a key point of intersection is   
eIF2- phosphorylation, which can be regulated by multiple ki-
nases and phosphatases (Wek et al., 2006). Several physiological 
inputs, including nutritional status, hypoxia, hormone stimulation,   
infection, and others, influence eIF2- phosphorylation both di-
rectly through other eIF2- kinases and indirectly. Notable among 
these kinases is PKR because it can be activated by signals that 
overlap with PERK activation such as viral infection and nutrient 
sensing (Baltzis et al., 2004; Nakamura et al., 2010). PERK also 
has been shown to phosphorylate, and thus activate, the NRF2 
transcription factor, linking PERK activation to a pathway more 
classically considered important in redox sensing (Cullinan et al.,   
2003; Cullinan and Diehl, 2004). Thus, the effect of PERK dur-
ing UPR activation is integrated with multiple other cellular con-
ditions to shape the downstream output.
For IRE1, activity may be controlled in part by interactions 
with BCL-2 family members (Hetz et al., 2006; Lisbona et al., 
2009) or PI3 kinase (Park et al., 2010; Winnay et al., 2010). IRE1 
also interacts with TRAF2 to influence signaling by its substrates, 
including JNK, ASK1, and perhaps nuclear factor B (NF-B; 
Urano et al., 2000; Nishitoh et al., 2002; Kaneko et al., 2003), 
suggesting that IRE1 might serve as a surprisingly broad signal 
transduction platform (Hetz and Glimcher, 2009). As with ATF6-, 
XBP1 activity can be regulated directly at the level of its inter-
action with target genes. Myogenic differentiation induces Xbp1 
splicing, and the subset of DNA sequences to which XBP1 can 
in turn would determine the output generated in response to that 
signal. The following examples illustrate how these principles are 
beginning to emerge in the field of UPR regulation.
The ability of cells to produce alternate outputs during UPR 
activation is most clearly illustrated by the observation that exces-
sive ER stress (that which a cell cannot successfully ameliorate 
via UPR activation) leads to programmed cell death, an outcome 
which is obviously incompatible with most instances of physio-
logical UPR activation. A physiological UPR must rely on mech-
anisms whereby adaptive UPR signaling can be maintained 
(potentially even perpetually) while apoptotic signaling is sup-
pressed. One UPR-mediated event of particular importance is up-
regulation of the transcription factor CHOP by ATF4 (Zinszner   
et al., 1998). Activation of the UPR by mild stress promotes long-
term up-regulation of ER chaperones, which are quite stable at 
the protein and mRNA levels. This presumably helps to improve 
ER folding and blunt the UPR, whereas rapid degradation of pro-
apoptotic components such as CHOP helps the cell escape death. 
However, when ER stress is severe, this mitigating action of the 
UPR is insufficient (Rutkowski et al., 2006). Conversely, it has 
been suggested that cells must attenuate protective features of the 
UPR, most notably IRE1- activation, to execute apoptosis when 
stress is severe (Lin et al., 2007). These alternate fates are an in-
trinsic consequence of the way that the UPR is structured, allow-
ing  cells  to  naturally  discriminate  strong  from  mild  stresses. 
However, the importance of proapoptotic UPR signaling compo-
nents such as CHOP in potentiating cell death suggests that they 
might also be regulated in trans at other points along the signaling 
axes that promotes their production.
One possible means of suppressing CHOP in trans, for ex-
ample, would be to maintain PERK in a quiescent state during 
UPR activation. Such selective inactivation would sacrifice the 
benefits  that  PERK  activation  provides  to  the  cell,  including 
ATF4-mediated up-regulation of amino acid biosynthetic path-
ways and redox defenses. Nonetheless, this appears to be exactly 
the mechanism used during plasma cell differentiation, during 
which CHOP is not robustly up-regulated (Gass et al., 2002), a 
finding which is subsequently attributed to the quiescence of 
PERK (Gass et al., 2008; Ma et al., 2010). In that context, ATF6- 
and IRE1- must be activated to up-regulate ER chaperones and 
expand the ER, yet PERK activation is undesirable. This is in part 
because of PERK’s effects on CHOP and also because PERK ac-
tivation would lead to translational repression, which would sub-
vert the increased Ig synthesis needed as the cells differentiate.
CHOP expression could also be regulated downstream of 
PERK activation, preserving the benefits of the latter. Such path-
way suppression was recently described during stimulation of 
cells by TLRs (Woo et al., 2009). These receptors, which signal 
the presence of pathogens, activate the UPR, perhaps in prepara-
tion for pathogen-mediated stress or as a consequence of in-
creased  ER  load  caused  by  cytokine  induction.  Remarkably, 
while triggering the UPR, TLR signaling simultaneously sup-
presses CHOP production at a step after eIF2- phosphorylation. 
This selective suppression permits cells to survive the stress of re-
sponding to pathogens by taking advantage of some, but not all, 
facets of the UPR. Indeed, because PERK suppression occurs 
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secondary or even tertiary event that is only distantly related to 
the underlying cause of disease. In this sense, UPR activity is 
simply a marker, and not necessarily a proximal one, of gener-
ally altered cellular function. A more relevant question is to ask 
under what circumstances ER stress and the UPR more directly 
contribute to disease.
The UPR would most obviously contribute to diseases 
caused by direct impairment of protein folding, of which there 
are three general classes. In the first class, a partial or complete 
defect in a UPR signaling component is anticipated to cause 
disease because the cells would be far less able to adjust some 
facet of their ER functionality to changing cellular conditions. 
This impairment would constrain the scope of physiological 
conditions to which the UPR could then effectively respond, 
and organs and cell types that place the greatest burden on that 
UPR component would be the first to evince pathology. Accord-
ing to this model, the organs most often affected would include 
the pancreas and liver, which are subject to constitutively heavy 
traffic through the secretory pathway and whose activities must 
be  modulated  constantly  to  meet  fluctuating  nutritional  and 
metabolic  needs.  Indeed,  PERK  loss  of  function  in  humans 
causes Wolcott-Rallison syndrome, a disease characterized by 
defects in many highly secretory cell types, including pancre-
atic  cells. Mice with analogous deficiencies in either PERK   
or  eIF2-  phosphorylation  develop  pancreatic  -cell  failure   
because they cannot tolerate the burden of regulated insulin   
production and secretion (Harding et al., 2001; Scheuner et al., 
2001; Zhang et al., 2002). Even more subtle deficiencies such as 
Xbp1 heterozygosity or a single nonphosphorylatable eIF2- 
allele lead to phenotypes when the animals are challenged with 
a high-fat diet that imposes greater physiological demands on 
the liver and pancreas (among other tissues; Özcan et al., 2004; 
Scheuner et al., 2005).
The converse of diseases arising from impaired UPR 
signaling is cancer, where UPR hyperactivation in tumor cells 
can  exacerbate  disease  by  protecting  them  from  cell  death. 
Alterations in UPR function are not typically found in screens 
for driver mutations producing oncogenic transformation (e.g., 
Jonkers and Berns, 1996; Collier et al., 2005), but altered UPR 
activity nonetheless appears to be important for progression and 
prognosis of at least some cancers (Carrasco et al., 2007; Lee, 
2007; Schewe and Aguirre-Ghiso, 2008). In such cases, UPR in-
volvement is not caused by genetic lesion of a UPR component 
but by positive feedback between the transformation process and 
UPR activation. It is thought that altered conditions of the trans-
formed cell, including rapid growth, high metabolic demand, 
and hypoxia, activate the UPR. This may favor adaptation, pro-
tection from cell death, and continued growth, thereby furthering 
transformation. The apparent ability of proteasome inhibitors to 
tip the balance of UPR activation toward apoptosis in multiple 
myeloma (Lee et al., 2003) hints at the importance of a properly 
regulated UPR, including its death-promoting activities, in 
cancer prevention.
The third class of diseases likely to be causally linked 
to the UPR and ER stress encompasses those directly involving 
globally compromised ER function, including protein misfold-
ing,  maintenance  of  calcium  homeostasis,  redox  balance,   
bind in that context overlaps only partially with those genes regu-
lated by XBP1 during classical ER stress (Acosta-Alvear et al., 
2007). This specificity in output likely reflects the influence of 
other transcriptional regulators specific to the differentiation pro-
cess that are capable of modulating XBP1 activity. Similarly, 
TLR stimulation can lead to IRE1-/XBP1 activation, giving rise 
to a pattern of gene expression quite distinct from the stress para-
digm (Martinon et al., 2010). Again, these interacting partners 
for eIF2-, IRE1, XBP1, etc. are not themselves static, and 
their abundance and activity can affect the output of UPR acti-
vation. Thus, all three UPR pathways are subject to modulation 
in trans by a variety of mechanisms involving rather diverse 
signaling pathways.
Finally, UPR output might also be regulated via the abun-
dance or activity of key UPR signaling molecules. Whether or 
how this abundance varies among cell types or historical events 
(e.g., whether the UPR was recently activated) is not well stud-
ied. However, modulating the expression of each of the key 
UPR molecules by small degrees (say, 10 or 20%) could have a 
significant combined effect on the sensitivity and output of the 
response. Notably, ATF6-, IRE1-, PERK, and ATF4 are all 
themselves transcriptionally regulated by UPR activation, and 
the relative amounts of the key UPR components could tune the 
response. For example, XBP1 protein translated from unspliced 
Xbp1 mRNA has been shown to antagonize transcriptional acti-
vation by the protein translated from the spliced mRNA (Tirosh 
et al., 2006; Yoshida et al., 2006). Thus, the steady-state ratio 
between these two forms of the XBP1 protein, controlled by the 
sum of regulation of Xbp1 mRNA expression and splicing, con-
trols transcriptional output.
These  and  yet  other  mechanisms  for  modulating  UPR   
activity at multiple points along each UPR branch illustrate the 
remarkably rich regulatory potential of the vertebrate UPR, 
which allows the response to achieve fine context specificity in 
ways that are only beginning to be uncovered. Thus, the UPR is 
capable of eliciting a rather wide range of qualitatively and 
quantitatively distinct outputs that are molded by both the na-
ture of the activating inputs and the context within which the 
UPR pathways operate. Understanding more precisely the scope 
of UPR functional diversity, as well as the detailed mechanisms 
by which that diversity is generated, represents a major chal-
lenge for the future.
Causal roles for the UPR in disease
Given the centrality of the ER to many cellular and organismal 
functions, it is quite likely to be associated with a variety of dis-
eases. Indeed, certain markers of UPR activation have been ob-
served in many disease states, which is not surprising because 
the signaling pathways of the UPR appear to respond to many 
stimuli and because the outputs of UPR signaling are so diverse. 
These diseases include cancer, diabetes, neurodegeneration, in-
fectious disease, autoimmunity, and many others (for review see 
Zhao and Ackerman, 2006). However, these associations are   
almost impossible to interpret from the standpoint of causality. 
In fact, given the interconnectedness of many cellular pathways 
and the ways cells interact within a complex organ system or 
organism, UPR activation in a given disease could well be a JCB • VOLUME 189 • NUMBER 5 • 2010   790
the ER (Laplante and Sabatini, 2009). Thus, both mTOR activ-
ity and VLDL biogenesis would be expected to increase load on 
the ER, which necessitates activation of the UPR to increase ER 
protein processing capacity (Özcan et al., 2004, 2008; Su et al., 
2009). Consistent with this idea, the UPR is activated in the liver 
during and after eating, and this activation is ameliorated by the 
inhibition of mTOR (Oyadomari et al., 2008; Pfaffenbach et al., 
2010). Although the stimulus of feeding can clearly be sensed by 
the cell, it can hardly be thought of as a stress in a conventional 
sense because simply eating a meal is unlikely to grossly impair 
ER function.
UPR signaling in the context of insulin action encom-
passes several pathways of negative feedback that, although per-
haps beneficial or largely irrelevant for the short-term nutrient 
fluctuations that occur during feeding and fasting cycles, may 
become detrimental in the context of chronic overnutrition. Among 
these pathways, activation of JNK by IRE1- (and possibly 
PKR; Nakamura et al., 2010) is particularly interesting because 
JNK phosphorylates the insulin receptor substrate (IRS-1), 
which then inhibits signaling through the insulin receptor (Tanti 
and Jager, 2009). Insulin signaling is further attenuated by UPR-
mediated autophagic destruction of the insulin receptor (Zhou   
et al., 2009). JNK can also activate proinflammatory cytokines, 
as can NF-B, another transcription factor which can also be ac-
tivated by the UPR (Zhang and Kaufman, 2008). UPR activation 
can also suppress VLDL secretion through the production of 
CHOP, which, in addition to promoting cell death during severe ER 
stress, can antagonize the regulation of metabolic gene expression 
etc. (for review see Zhao and Ackerman, 2006). Here, the inciting 
event would be a chronic additional load on the ER, resulting in 
activation of the UPR to remediate the stress by increasing the 
functional capacity of the ER. At some point, the capacity to re-
spond would be overwhelmed, resulting eventually in cell death. 
That such disease states are caused mainly by UPR-mediated 
cell death is supported by the fact that in some cases, CHOP ab-
lation at least partially rescues the phenotype (Silva et al., 2005; 
Pennuto et al., 2008; Song et al., 2008; Namba et al., 2009; 
Thorp et al., 2009). Diseases in this class could be caused by 
mutations in secretory pathway client proteins or in the ER pro-
tein folding machinery.
A noteworthy observation from patients with such diseases 
(and analogous mouse models) is that even an inciting event that 
occurs universally (or widely) often leads to considerable cell 
type–specific pathology (e.g., Zhao et al., 2005). This under-
scores the notion that the cellular context in which a perturbation 
occurs shapes the capacity to adapt to or absorb that perturbation. 
Similarly, because the capacity of the ER to carry out its various 
functions, and that of the UPR to respond, can change during 
development and aging (Naidoo, 2009), disease phenotypes are 
often temporally regulated and age dependent. Neurodegenera-
tive disorders are classical examples of age-related diseases in 
which the UPR has been implicated (Paschen and Mengesdorf, 
2005). Although no definitive causal relationship has been es-
tablished between Alzheimer’s disease, Parkinson’s disease, 
Huntington’s disease, and other such disorders and the UPR, it 
is tempting to speculate that neurons, which enjoy privilege from 
most environmental fluctuations that challenge other cell types, 
might be especially sensitive to progressive perturbations such 
as proteotoxicity.
UPR pathway interactions in disease
Beyond the predictable disease-causing effects of deficiencies in 
either UPR components or protein folding, how else might path-
ological states be caused by the UPR? Is it possible that UPR 
activation in response to a given stimulus can be beneficial under 
one set of conditions but detrimental under another depending 
on the context in which activation occurs? Pathogenesis by such 
a mechanism would not involve a specific lesion or deficiency 
but rather a more nuanced system-wide change in how a com-
plex set of homeostatic pathways interact and are organized. To 
illustrate this idea, we consider the role of UPR signaling in liver 
metabolism and insulin action, which has been a topic of several 
recent studies.
Nutrient availability fluctuates constantly in response to   
feeding and fasting cycles. Among the many consequences of 
this flux is the secretion of insulin by pancreatic  cells, an event 
which has many downstream consequences in insulin target 
tissues. At least two of these consequences are capable of influ-
encing the ER (Fig. 3). First, insulin signaling up-regulates the 
central nutrient-sensing mammalian target of rapamycin (mTOR) 
pathway (Hietakangas and Cohen, 2009). Activation of mTOR 
favors anabolism, including increased protein synthesis. Second, 
insulin signaling stimulates both lipogenesis and cholesterolo-
genesis by activating SREBP-1c and SREBP2 in the liver to fa-
cilitate the production of very low-density lipoprotein (VLDL) in 
Figure  3.  UPR-mediated  feedback  inhibition  of  insulin  signaling.  
Nutritional intake upon feeding stimulates insulin release, which initiates 
at least two signaling pathways in the liver (green) that impact the ER in 
distinct ways. First, enhanced protein synthesis caused by mTOR activation 
increases general substrate load in the ER. Second, activation of SREBP 
pathways stimulate production of lipoproteins such as VLDL, whose compo-
nents are assembled in the ER. These (and possibly other) effects activate 
the UPR, which can inhibit insulin action by multiple feedback mechanisms 
(orange). Although this feedback inhibition likely serves a beneficial role 
during the postprandial state, it could become deleterious during chronic 
overnutrition. IR, insulin receptor; IRS, IR substrate.791 Physiologic regulation of the UPR • Rutkowski and Hegde
are not adaptive to the organism, thus contributing to the pathology. 
Therefore, understanding the nuances of the interactions of UPR 
pathways with the cellular context will continue to be crucial in 
dissecting the pathogenesis of complex, chronic, multifactorial 
diseases such as metabolic syndrome, inflammation, neuro-
degeneration, cancer, and others.
Future aims and challenges
Although the UPR was originally identified as a response to acute 
ER perturbation and clearly serves that function in physiologi-
cally meaningful ways, it is now evident that UPR signaling path-
ways are enmeshed with cellular physiology in more complex 
and subtle ways. We have highlighted several observations illus-
trating that inputs into the UPR are considerably more diverse 
and nuanced than solely protein misfolding stress and that UPR 
outputs are highly complex, quite malleable, and strongly influ-
enced by cellular context. The considerable flexibility in the way 
these pathways are engaged allows them to be deployed under a 
rather wide range of physiological conditions that intersect in one 
way or another with ER homeostasis. Conversely, the same com-
plex set of UPR pathway interactions, while providing consider-
able regulation and flexibility, also carries greater opportunity for 
misappropriation in a variety of pathological contexts. We are 
only just glimpsing the mechanisms that allow a core set of UPR 
pathways to be differentially responsive in a context-dependent 
manner to regulate diverse outputs.
It is clear that if we are to fully appreciate the range of UPR 
regulation in physiology and pathophysiology, we will need sys-
tems and methods that differ qualitatively from those used to elu-
cidate the core stress-initiated pathways. First, it will be necessary 
to develop model systems for experimentally inducing and study-
ing physiological activation of the UPR. Because the inputs that 
initiate the UPR are diverse, it is likely that different specific ex-
perimental systems will be needed to understand the range of 
mechanisms by which each UPR component can be selectively 
activated or selectively suppressed. Second, we will need tools 
for manipulating (turning on, turning off, and tuning) individual 
UPR pathways with higher spatial and temporal resolution. An 
attractive system in this respect is the chemical genetic tools that 
have been developed that allow exogenously expressed PERK 
and IRE1- to be specifically activated in the absence of stress 
(Papa et al., 2003; Lu et al., 2004). In the case of IRE1-, such 
activation allows for dissociation of its Xbp1 splicing and RIDD-
stimulating activities (Han et al., 2009). Such chemical genetic 
strategies, in combination with tissue-specific transgene expres-
sion (or, more optimally, knockin expression), would allow highly 
precise experimental manipulation of UPR pathways to test their 
roles in complex physiology. This will be the next stage of refine-
ment beyond conditional knockouts, the current state of the art, 
needed to probe causal relationships between the UPR and spe-
cific physiological and pathological states.
Paralleling the implementation of better methods for   
inducing UPR pathways will be the development of in vivo   
biosensors for monitoring both UPR activation and the various 
UPR-regulated  functions,  including  protein  folding,  mainte-
nance of calcium homeostasis, and lipid synthesis. The develop-
ment of a transgenic mouse expressing an IRE1-responsive 
(Rutkowski et al., 2008). In the context of normal feeding and 
fasting cycles, these signaling pathways likely contribute to nor-
mal feedback inhibition of insulin action at multiple points along 
the cascade (Fig. 3). However, when nutritional excess and rela-
tively constant insulin signaling is the norm, they may contrib-
ute to a chronically altered state. In this context, these normally 
beneficial UPR activities could lead to insulin resistance (as a 
consequence of persistent IRS-1 phosphorylation and insulin re-
ceptor degradation), elevated cytokine levels (via both JNK and 
NF-B), fatty liver (by inhibition of VLDL secretion), and other 
UPR-mediated effects on metabolism (Hotamisligil, 2010). Some 
of these effects (e.g., elevated cytokine levels) could lead to fur-
ther UPR activation, setting up a positive feedback loop that 
sustains unalleviated UPR activation, inflammation, and chronic 
insulin resistance.
Indeed, this aforementioned sequence of events centered on 
UPR signaling is emerging as a key pathogenic mechanism in 
models of type 2 diabetes. Although many aspects of this model 
remain to be rigorously established, the model is consistent with 
several studies in which the UPR or ER functionality is experi-
mentally manipulated. For example, JNK deficiency leads to   
protection from diet-induced insulin resistance (Hirosumi et al., 
2002), whereas constitutive mTOR activation causes marked in-
sulin resistance (Shah et al., 2004). With respect to the ER, mice 
heterozygous for Xbp1 are unable to reestablish ER homeostasis 
as efficiently, and they develop increased insulin resistance more 
readily than wild-type animals in response to overnutrition, con-
comitant with increased JNK activation (Özcan et al., 2004). 
Conversely, chemical chaperones or BiP overexpression improve 
insulin sensitivity, perhaps caused by dampened signaling via 
UPR pathways that initiate the aforementioned positive feedback 
loops (Özcan et al., 2006; Kammoun et al., 2009).
Together, the aforementioned studies illustrate that the inte-
gration of UPR pathways with metabolic pathways, at the levels 
of both signaling and at the level of transcriptional control, makes 
UPR outputs highly dependent on the cellular context. This is 
because each metabolic state (e.g., fed, fasted, high fat, low fat, 
etc.) will, in addition to regulating the UPR, also modulate inde-
pendent signaling cascades with which the UPR can then inter-
act. Thus, the connections between the UPR and metabolism can 
be understood as autoregulatory mechanisms that are normally 
beneficial and work to mutually promote ER homeostasis and 
a suitable cellular energy balance. These connections between 
pathways then become deleterious only in special contexts, such 
as chronic overnutrition, that are unlikely to have been commonly 
encountered during the evolution of UPR pathways. Thus, un-
ameliorated ER stress (i.e., misfolded protein accumulation be-
yond ER processing capacity) may not feature prominently in 
such diseases; instead, the pathological events are likely caused 
by physiological UPR activation in combination with altered en-
vironmental context.
In a broader sense, many disease states in which UPR acti-
vation is implicated may not necessarily reflect misfolded protein 
stress, given that this is not the sole means of UPR activation. 
UPR-associated disease states may instead reflect the appropriate 
engagement of UPR pathways by physiological inputs, but within 
a cellular or environmental context where the pathway outputs JCB • VOLUME 189 • NUMBER 5 • 2010   792
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by a direct interaction with IRE1alpha. Science. 312:572–576. doi:10.1126/ 
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Hietakangas, V., and S.M. Cohen. 2009. Regulation of tissue growth through 
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fluorescent indicator is an important first step; biosensors that 
sensitively report on other UPR pathways at points both prox-
imal and distal to UPR activation will also be necessary. Like-
wise, probes for assessing ER calcium handling and, more 
recently,  the  ER  folding  environment  (Merksamer  et  al., 
2008) have been developed for use in cultured cells and sim-
ple organisms; these must now be adapted for use in vivo in 
vertebrates. Biosensors of this sort will be necessary in part 
because, in most tissues, UPR pathways will likely be acti-
vated to a very modest extent, such that detection will require 
amplification. Once such methods are developed, it will be 
possible to use them to follow the ebb and flow of UPR path-
way activation in vivo in response to stimuli such as feeding 
and fasting cycles.
Finally, the interconnection between the UPR and other 
cellular signaling pathways will be best understood when stud-
ied as an integrated whole. Fortunately, the methods available for 
quantitative and global analysis of cellular responses to altera-
tions in homeostasis are expanding exponentially. The ability to 
analyze whole “omes” (transcriptome, proteome, metabolome, 
and epigenome) in combination with sophisticated computational 
tools for integrating the vast amounts of data generated by these 
analyses will allow us to visualize the UPR less as series of lin-
ear pathways with discrete endpoints and more as a contextually 
dependent contributor to a complex and dynamic signaling net-
work that maintains cellular homeostasis. Indeed, such tools are 
already being applied to simple organisms (Jonikas et al., 2009), 
and it is only a matter of time before they can be applied to the 
vertebrate UPR as well.
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